BridgeBio Pharma is seeking a Skeletal Dysplasia Account Manager for the Northeast Region. This remote position focuses on launching Infigratinib, a therapy for achondroplasia, through strategic partnerships with healthcare providers.
The ideal candidate will have significant experience in the pharmaceutical or biotech industries, particularly in rare diseases. This role offers competitive compensation, including stock options and market-leading benefits.
#J-18808-LjbffrSkeletal Dysplasia Territory Manager (Remote Northeast) in Remote at Unknown Company
This position is listed as full time and able to be worked remotely.